For more than 70 years methotrexate has been a popular tool in the prescription toolkit of doctors around the world. However, a recent case report by a team from the United Kingdom showed how important it is for prescribing doctors to also keep a close eye on some of the well-known adverse events associated with the medication.
Researchers at Wake Forest Baptist Medical Center have released a study showing the potential of a dangerous interaction between a common supplement and prescription medication.
Among patients aged 65 years or older who are hospitalized with community-acquired pneumonia, azithromycin lowers the risk of 90-day mortality in exchange for slightly increased odds of myocardial infarction compared to other antibiotic regimens.
Men who have sex with men and women (MSMW) have unique vulnerability to HIV and sexually transmitted infections (STIs) and other sexual health problems, according to a review published online June 22 in American Journal of Preventive Medicine.
A new pill could be the next tool in a patient's fight to lose weight, according to a recent study.
This marks the first testosterone nasal gel for replacement therapy in adult males approved by the FDA for conditions associated with a deficiency or absence of endogenous testosterone.
Researchers in Saint Louis are examining the ways in which a drug already approved for multiple sclerosis could ease some of the pain associated with chemotherapy for cancer patients.
The brains of hyperglycemic patients with Type 1 diabetes produce elevated levels of the neurotransmitter glutamate, which may increase their risk of depression.
A retrospective cohort study of Medicare beneficiaries hospitalized for heart failure with a left ventricular ejection fraction between 30-35% found improved 3-year survival rates among those who received a prophylactic implantable cardioverter-defibrillators compared to those with no ICD.
New research has reached the unexpected conclusion that non-steroidal anti-inflammatory drugs (NSAIDs) may rank among the top causes of drug-induced anaphylaxis.
A recent review found that tonabersat, a novel benzoylamino benzopyran compound, is well-tolerated, but no better than placebo for migraine prophylaxis.
Researchers find that the ratio of total cholesterol to HDL is a significant predictor for CVD in type 1 diabetes patients who are not using lipid-lowering drugs, and that the ratio of total cholesterol to HDL is a more reliable marker for risk when considering primary prevention.
Contrary to popular belief, patients who are prescribed antidepressants experience only minimal weight gain within 12 months of treatment.
The US Food and Drug Administration partially lifted a clinical hold on a hepatitis C drug under development by Achillion Pharmaceuticals, clearing the way for a restart of the company's clinical trials of sovaprevir.
Comparatively few patients treated for anaphylaxis in the emergency department are prescribed adrenaline autoinjectors, and many who do receive them either do not know how to properly use the device or fail to carry it with them at all times.
Prebiotics and probiotics have been discussed frequently in the media for supposedly improving overall health, especially diseases related to the gut. However, the evidence on the efficacy and use of these dietary supplements is rather complicated.
After studying an Amish population, researchers at the University of Maryland Medical Center have discovered a mutation in a fat-storage gene that increases a patient's risk for type 2 diabetes.
The American Society of Hypertension (ASH) is the largest US professional organization dedicated to eradicating hypertension and its consequences. The following study presentations were highlights of the organization's 29th annual meeting in New York City.
Internists must resist taking as much as they can carry from the current healthcare system just because they can get away with it.
Coping strategies based on enhanced mindfulness and a greater sense of agency can help patients improve their quality of life.
Barrett's esophagus is frequently overdiagnosed in clinical settings, which has broad implications for patient health, medical costs, and psychological stress due to perceived cancer risk.
Results from two studies show that treatment with the novel kinase inhibitor nintedanib significantly slowed disease progression in patients with idiopathic pulmonary fibrosis (IPF). However, only one study showed nintedanib had any effect on slowing deterioration in quality of life or reducing the risk of a first acute exacerbation compared with placebo.
Patients with mental health disorders are significantly more likely to have used or currently use electronic cigarettes.
